Monday, September 14, 2026

BabyMonster’s ‘DRIP’: Behind the Scenes of a Musical Masterpiece

BabyMonster reveals the recording process of "DRIP," showcasing their dedication and talent ahead of their debut world tour.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

North Korea Dismisses APEC Invitation Talk as ‘Vain Delusions’

North Korea's Kim Jong Un unlikely to attend APEC summit, with officials dismissing South Korea's invitation proposals as unrealistic.

Tag: CKDB-501A

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us